awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30474759-BE8807F6-4137-440D-9C24-170DDB1E1D78
Q30474759-BE8807F6-4137-440D-9C24-170DDB1E1D78
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30474759-BE8807F6-4137-440D-9C24-170DDB1E1D78
Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions
P2860
Q30474759-BE8807F6-4137-440D-9C24-170DDB1E1D78
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30474759-BE8807F6-4137-440D-9C24-170DDB1E1D78
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5d660148f06f519e7d94204138c0435ed6d372fa
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.